Literature DB >> 15507310

The primary GP5 neutralization epitope of North American isolates of porcine reproductive and respiratory syndrome virus.

Peter G W Plagemann1.   

Abstract

I have used indirect ELISA with overlapping synthetic peptides representing the GP5 ectodomain to study the generation and specificity of peptide-binding Abs in pigs that were infected in utero with porcine reproductive and respiratory syndrome virus (PRRSV) strain VR2332 and in North American field sera submitted for PRRSV infection diagnosis. Peptide-binding Abs appeared in sera of the VR2332-infected pigs within about 30 days post-farrowing (dpf), reaching maximum titers 100-200 dpf and then decreasing slowly to about half of maximum titer by about 400 dpf. The formation of peptide-binding Abs and of virus neutralizing Abs correlated and their initial appearance coincided with disappearance of virus from the circulation. The Abs were specific for VR2332-specific peptides. In contrast, anti-N-protein Abs as measured by HerdCheck ELISA appeared within 7 dpf, reached maximum levels at about 100 dpf and had decreased below detectable levels by about 200 dpf. Twenty-seven field serum samples with virus neutralizing activity all possessed high levels of peptide binding Abs, but the Abs bound about equally to VR2332 and strain Lelystad virus (LV)-specific peptides. The indirect ELISA results using various large peptides and competition ELISA using small peptides (8 or 9 amino acids long) confirmed that the epitope recognized by the Abs is located in the GP5 ectodomain sequence 37SHLQLIYNL of VR2332. Use of mutated peptides in the competition ELISA showed that 42I to T and 38HL to TY substitutions blocked Ab recognition, whereas deletion of 41L had no effect. In addition, 26 serum samples submitted by two farms for diagnostic tests were found to possess low levels of Abs that bound to GP5 ectodomain peptides, even though the sera were sero-negative in the HerdChek ELISA and lacked neutralizing activity. Competition ELISA showed that the Abs recognized one or more epitopes located downstream of the PRRSV neutralization epitope. An epitope(s) located in the same area was recognized by Abs generated in mice by immunization with a GP5 ectodomain peptide conjugated to BSA. These Abs also lacked neutralizing activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15507310     DOI: 10.1016/j.vetimm.2004.09.011

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  33 in total

1.  Evaluation of the new commercial recombinant chimeric subunit vaccine PRRSFREE in challenge with heterologous types 1 and 2 porcine reproductive and respiratory syndrome virus.

Authors:  Jiwoon Jeong; Changhoon Park; Kyuhyung Choi; Chanhee Chae
Journal:  Can J Vet Res       Date:  2017-01       Impact factor: 1.310

2.  Molecular assessment of the role of envelope-associated structural proteins in cross neutralization among different PRRS viruses.

Authors:  Won-Il Kim; Kyoung-Jin Yoon
Journal:  Virus Genes       Date:  2008-09-03       Impact factor: 2.332

3.  Molecular epidemiology of PRRSV from China's Guangxi Province between 2007 and 2009.

Authors:  Hong-Yun Zhang; Jing-Jing Liang; Xian-Ming Meng; Hui Li; Jian Yang; Li-Juan Su; Hong-Pu Zhang; Lin-Juan Xie; Xiao-Xia He; Yan-Sheng Li; Shan Yin; Xiao-Quan Li; Xiao-Ning Li; Ting Rong Luo
Journal:  Virus Genes       Date:  2012-09-25       Impact factor: 2.332

4.  Within-Host Evolution of Simian Arteriviruses in Crab-Eating Macaques.

Authors:  Louise H Moncla; Andrea M Weiler; Gabrielle Barry; Jason T Weinfurter; Jorge M Dinis; Olivia Charlier; Michael Lauck; Adam L Bailey; Victoria Wahl-Jensen; Chase W Nelson; Joshua C Johnson; Yíngyún Caì; Tony L Goldberg; David H O'Connor; Peter B Jahrling; Jens H Kuhn; Thomas C Friedrich
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

5.  Identification of epitopes on nonstructural protein 7 of porcine reproductive and respiratory syndrome virus recognized by monoclonal antibodies using phage-display technology.

Authors:  Heng Wang; Rongchang Liu; Weidong Zhang; Lingshuang Sun; Zhangyong Ning; Fangxiao Ji; Jin Cui; Guihong Zhang
Journal:  Virus Genes       Date:  2017-06-08       Impact factor: 2.332

6.  Arteriviruses, Pegiviruses, and Lentiviruses Are Common among Wild African Monkeys.

Authors:  Adam L Bailey; Michael Lauck; Ria R Ghai; Chase W Nelson; Katelyn Heimbruch; Austin L Hughes; Tony L Goldberg; Jens H Kuhn; Anna J Jasinska; Nelson B Freimer; Cristian Apetrei; David H O'Connor
Journal:  J Virol       Date:  2016-07-11       Impact factor: 5.103

7.  Immunopotentiation of four natural adjuvants co-administered with a highly pathogenic porcine reproductive and respiratory syndrome virus glycoprotein 5 subunit.

Authors:  Jun Peng; Yanmei Yuan; Si Shen; Zhongxiang Niu; Yijun Du; Jiaqiang Wu; Jun Li; Jiang Yu; Tao Wang; Jinbao Wang
Journal:  Virus Genes       Date:  2016-02-08       Impact factor: 2.332

8.  Antigen-specific B-cell responses to porcine reproductive and respiratory syndrome virus infection.

Authors:  Prasad Mulupuri; Jeffrey J Zimmerman; Joseph Hermann; Craig R Johnson; Jean Paul Cano; Wanqin Yu; Scott A Dee; Michael P Murtaugh
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

9.  The M/GP(5) glycoprotein complex of porcine reproductive and respiratory syndrome virus binds the sialoadhesin receptor in a sialic acid-dependent manner.

Authors:  Wander Van Breedam; Hanne Van Gorp; Jiquan Q Zhang; Paul R Crocker; Peter L Delputte; Hans J Nauwynck
Journal:  PLoS Pathog       Date:  2010-01-15       Impact factor: 6.823

10.  Genetic analysis of ORF5 of recent Korean porcine reproductive and respiratory syndrome viruses (PRRSVs) in viremic sera collected from MLV-vaccinating or non-vaccinating farms.

Authors:  Hye Kwon Kim; Jeong Sun Yang; Hyoung Joon Moon; Seong Jun Park; Yuzi Luo; Chul Seung Lee; Dae Sub Song; Bo Kyu Kang; Soo Kyung Ann; Chan Hyuk Jun; Bong Kyun Park
Journal:  J Vet Sci       Date:  2009-06       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.